Pharvaris N.V. (PHVS) Social Stream
PHARVARIS NV (PHVS) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering PHVS.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-12 | 4 | $51 | $21 | $42.5 | $25.42 | 67.19% |
| 2022-01-18 | 4 | $50 | $21 | $42.25 | $25.42 | 66.21% |
| 2022-02-07 | 3 | $50 | $21 | $40 | $25.42 | 57.36% |
| 2022-04-04 | 4 | $50 | $21 | $40 | $25.42 | 57.36% |
| 2022-04-26 | 4 | $48 | $21 | $38.75 | $25.42 | 52.44% |
| 2022-05-16 | 4 | $48 | $21 | $38.5 | $25.42 | 51.46% |
| 2022-05-25 | 5 | $48 | $21 | $37.6 | $25.42 | 47.92% |
| 2022-05-27 | 5 | $48 | $20 | $37.4 | $25.42 | 47.13% |
| 2022-07-06 | 5 | $48 | $20 | $37.4 | $25.42 | 47.13% |
| 2022-08-13 | 5 | $48 | $26 | $38.6 | $25.42 | 51.85% |
| 2022-08-23 | 5 | $34 | $10 | $20.8 | $25.42 | -18.17% |
| 2022-11-02 | 5 | $22 | $10 | $16.6 | $25.42 | -34.7% |
| 2022-12-08 | 5 | $22 | $5 | $15 | $25.42 | -40.99% |
| 2022-12-09 | 5 | $24 | $8 | $16.8 | $25.42 | -33.91% |
| 2023-01-27 | 5 | $24 | $8 | $17 | $25.42 | -33.12% |
| 2023-04-05 | 5 | $24 | $8 | $16.6 | $25.42 | -34.7% |
| 2023-06-06 | 5 | $24 | $8 | $16 | $25.42 | -37.06% |
| 2023-06-27 | 5 | $26 | $8 | $16.8 | $25.42 | -33.91% |
| 2023-08-14 | 5 | $26 | $8 | $17.6 | $25.42 | -30.76% |
| 2023-08-15 | 5 | $34 | $8 | $22.4 | $25.42 | -11.88% |
| 2023-08-17 | 6 | $34 | $8 | $22.4 | $25.42 | -11.88% |
| 2023-10-18 | 6 | $34 | $8 | $23.166 | $25.42 | -8.87% |
| 2023-11-13 | 6 | $34 | $8 | $22.666 | $25.42 | -10.83% |
| 2023-11-17 | 6 | $32 | $8 | $22.333 | $25.42 | -12.14% |
The Trend in the Analyst Price Target
Over the past 27 months, PHVS's average price target has gone down $20.98.
Over the past 49 weeks, PHVS's average upside potential has been 46.35%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-27 | 5 | 24 | 8 | 17.000 | 9.46 | 79.7% |
| 2023-06-27 | 5 | 26 | 8 | 16.800 | 16.00 | 5% |
| 2023-08-09 | 5 | 26 | 8 | 17.600 | 17.25 | 2.03% |
| 2023-08-17 | 6 | 34 | 8 | 22.400 | 19.32 | 15.94% |
| 2023-10-18 | 6 | 34 | 8 | 23.166 | 19.80 | 17% |
PHVS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.5 | 5 | 0 | 0 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
PHVS's average broker recommendation rating improved by 0.5 over the prior 13 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, PHARVARIS NV's variance in analysts' estimates is lower than -1993.84% of them.
- To contextualize these metrics, consider that out of all US stocks, PHARVARIS NV's upside potential (average analyst target price relative to current price) is greater than 745.09% of them.
- In terms of how PHARVARIS NV fares relative to Healthcare stocks, note that its number of analysts covering the stock is greater than 619.73% of that group.
- In terms of how PHARVARIS NV fares relative to stocks in the small market cap category, note that its average analyst price target is higher than 1609.59% of that group.
Stocks similar to PHARVARIS NV in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ADAG, LGVN, and CNTB.
View All Top Stocks by Price Target
Make investment decisions regarding PHVS using the data that counts. Try POWR Ratings for free.